Yuan TianFrom Target to Therapeutics with Humanized Mouse ModelsExplore how humanized mice are transforming lab findings into real-life therapeutics with Biocytogen’s cutting-edge mouse models.4d ago
Andrew HesselinThe Quantastic JournalCan fighting cancer be made into a game?Genome sequencing, artificial intelligence, and synthetic biology are all booming, so why are we still fighting cancer with Big Pharma’s…Mar 135
Pharmabeej3 Practical Difference Between Assay Potency And Purity In Pharmaceutical “ PharmabeejIn the pharmaceutical industry, the difference between assay potency and purity is a major problem to understand for the newbies and…Oct 15, 2020Oct 15, 2020
Princeton BiopartnersPositioning for Value Based Care in Next Generation Immuno-TherapyAbstract: Second generation immunotherapeutics are associated with a rise in combination treatment strategies, an introduction of novel…Jul 26Jul 26
Sui Huang, MD, PhDWill ARPA-H finally Win the War on Cancer? Not Without a Big Rethink.Cancer is a complex, resilient adaptive system. Simply using technology to identify those cancer cells in the relapsing tumor that resist…May 31May 31
Yuan TianFrom Target to Therapeutics with Humanized Mouse ModelsExplore how humanized mice are transforming lab findings into real-life therapeutics with Biocytogen’s cutting-edge mouse models.4d ago
Andrew HesselinThe Quantastic JournalCan fighting cancer be made into a game?Genome sequencing, artificial intelligence, and synthetic biology are all booming, so why are we still fighting cancer with Big Pharma’s…Mar 135
Pharmabeej3 Practical Difference Between Assay Potency And Purity In Pharmaceutical “ PharmabeejIn the pharmaceutical industry, the difference between assay potency and purity is a major problem to understand for the newbies and…Oct 15, 2020
Princeton BiopartnersPositioning for Value Based Care in Next Generation Immuno-TherapyAbstract: Second generation immunotherapeutics are associated with a rise in combination treatment strategies, an introduction of novel…Jul 26
Sui Huang, MD, PhDWill ARPA-H finally Win the War on Cancer? Not Without a Big Rethink.Cancer is a complex, resilient adaptive system. Simply using technology to identify those cancer cells in the relapsing tumor that resist…May 31
Kulika WeizmanDecoding AI’s True Impact on Drug DevelopmentTraditionally, drug discovery and development have been viewed as binary: a drug either progresses through clinical trials and approval or…Jul 21
Aftab MohammadHow I Built a Generative AI Model that can Generate Novel Small Molecules for Drug Discovery!Check out how you can make a Gen AI model that creates new molecules for drug development!Jan 7
kiran kumarTowards Faster Drug Development: A Pilot Study on a Low-Cost, Non-Invasive Device for Real-Time…Abstract:Jul 14